Magenta Therapeutics, Inc.
(NASDAQ GM: MGTA)
Rigrodsky Law, P.A. is investigating Magenta Therapeutics, Inc. (“Magenta”) regarding possible breaches of fiduciary duties and other violations of law related to Magenta’s agreement to merge with Dianthus Therapeutics, Inc.